---
schema_version: "secwatch.filing_event.v1"
accession: "0001689548-23-000150"
form_type: "8-K"
ticker: "PRAX"
cik: "0001689548"
company_name: "Praxis Precision Medicines, Inc."
filed_at: "2023-11-06T23:59:59+00:00"
generated_at: "2026-06-08T21:09:36.077604+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Praxis stockholders approve reverse stock split at ratio 1:5 to 1:25

## Summary
- Reverse stock split proposal approved with 85,952,274 votes for, 21,357,155 against, 2,355 abstain.
- Board authorized to set split ratio between 1-for-5 and 1-for-25 at its discretion.
- Adjournment proposal also approved: 85,270,203 for, 22,026,296 against, 15,285 abstain.
- No other matters were submitted to or voted on at the special meeting.

## SEC filing metadata
- accession: 0001689548-23-000150
- form_type: 8-K
- ticker: PRAX
- cik: 0001689548
- company_name: Praxis Precision Medicines, Inc.
- filed_at: 2023-11-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1689548/000168954823000150/0001689548-23-000150-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1689548/000168954823000150/prax-20231106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001689548-23-000150
- JSON: https://secwatch.observer/filing/0001689548-23-000150.json
- Plain text: https://secwatch.observer/filing/0001689548-23-000150.txt

## Key facts
- Shareholder Votes
  Praxis Precision Medicines, Inc. shareholders approved Approval of amendments to the Amended and Restated Certificate of Incorporation to give the Board discretionary authority to effect a reverse stock split at a ratio ranging from 1-for-5 to 1-for-25 at the 2023-11-06 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2023-11-06
  source text: The Company’s stockholders approved amendments to the Company’s Amended and Restated Certificate of Incorporation to give the Company’s Board of Directors discretionary authority to effect a reverse stock split of all of the outstanding shares of the Company’s common stock, par value $0.0001 per share, at a ratio ranging from any whole number between 1-for-5 and 1-for-25, as determined by the Company’s Board of Directors in its discretion and included in a public announcement (the “Reverse Stock Split Proposal”), with the votes cast as follows: Votes For Votes Against Abstain Broker Non-Vote 85,952,274 21,357,155 2,355 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1689548/000168954823000150/0001689548-23-000150-index.htm
- Shareholder Votes
  Praxis Precision Medicines, Inc. shareholders approved Proposal to adjourn the Special Meeting to a later date, if necessary, to permit further solicitation of proxies in connection with the Reverse Stock Split Proposal at the 2023-11-06 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2023-11-06
  source text: The Company’s stockholders approved a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Reverse Stock Split Proposal, with the votes cast as follows: Votes For Votes Against Abstain Broker Non-Vote 85,270,203 22,026,296 15,285 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1689548/000168954823000150/0001689548-23-000150-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.